QSM as an imaging biomarker for Alzheimer’s disease
Quantitative susceptibility mapping as an imaging biomarker for Alzheimer’s disease: The expectations and limitations Yuto Uchida, Hirohito Kan, Keita Sakurai,[…]
WeiterlesenQuantitative susceptibility mapping as an imaging biomarker for Alzheimer’s disease: The expectations and limitations Yuto Uchida, Hirohito Kan, Keita Sakurai,[…]
WeiterlesenBrain pathological changes during neurodegenerative diseases and their identification methods: How does QSM perform in detecting this process? Farzaneh Nikparast,[…]
WeiterlesenOn November 17, 2021, after eight months of work and a consultation in which some forty stakeholders participated, the French[…]
WeiterlesenCorrelations between soluble alpha/beta forms of amyloid precursor protein and Abeta38, 40 and 42 in human cerebrospinal fluid Audrey Gabelle,[…]
Weiterlesen510(k) Premarket Notification Device Classification Name system, nuclear magnetic resonance imaging 510(k) Number K210415 Device name QSM software, QSMetric Applicant[…]
WeiterlesenAccurate quantification of magnetic susceptibility in molecular mri Inventor: Yi Wang, Ludovic De Rochefort, Bryan Kressler, Tian LIU, Pascal Spincemaille
WeiterlesenImaging the aging brain: study design and baseline findings of the SENIOR cohort Alexa Haeger, Jean-François Mangin, Alexandre Vignaud, Cyril[…]
WeiterlesenClinical Integration of Quantitative Susceptibility Mapping Magnetic Resonance Imaging into Neurosurgical Practice S. Kathleen Bandt, Ludovic de Rochefort, Weiwei Chen,[…]
WeiterlesenOptimisation théorique et expérimentale de la technique IRM du transfert d’aimantation inhomogène pour l’imagerie de la myéline : application à[…]
WeiterlesenClinical Integration of Automated Processing for Brain Quantitative Susceptibility Mapping: Multi-Site Reproducibility and Single-Site Robustness Pascal Spincemaille, Zhe Liu, Shun[…]
Weiterlesen